Krajewski W - Search Results

1

Glycosaminoglycan Replacement Therapy with Intravesical Instillations of Combined Hyaluronic Acid and Chondroitin Sulfate in Patients with Recurrent Cystitis, Post-radiation Cystitis and Bladder Pain Syndrome: A Narrative Review.

Poletajew S, Brzózka MM, Krajewski W, Kamecki H, Nyk Ł, Kryst P. Poletajew S, et al. Among authors: krajewski w. Pain Ther. 2024 Feb;13(1):1-22. doi: 10.1007/s40122-023-00559-1. Epub 2023 Nov 2. Pain Ther. 2024. PMID: 37917298 Free PMC article. Review.

2

Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 Patients.

Krajewski W, Matuszewski M, Poletajew S, Grzegrzółka J, Zdrojowy R, Kołodziej A. Krajewski W, et al. Urol Int. 2018;101(3):277-284. doi: 10.1159/000492722. Epub 2018 Sep 18. Urol Int. 2018. PMID: 30227437

3

Influence of Transurethral Resection of Bladder Cancer on Sexual Function, Anxiety, and Depression.

Krajewski W, Halska U, Poletajew S, Piszczek R, Bieżyński B, Matyjasek M, Tukiendorf A, Menzel F, Mazur M, Rymaszewska J, Zdrojowy R. Krajewski W, et al. Adv Exp Med Biol. 2018;1116:37-50. doi: 10.1007/5584_2018_264. Adv Exp Med Biol. 2018. PMID: 30242788

4

The Optimal Timing of Restaging Resection before Introduction of Bacillus Calmette-Guerin Immunotherapy in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.

Krajewski W, Zdrojowy R, Dembowski J, Poletajew S, Wróbel M, Łuczak M, Tukiendorf A, Kolodziej A. Krajewski W, et al. Urol Int. 2019;102(1):60-68. doi: 10.1159/000491642. Epub 2018 Sep 28. Urol Int. 2019. PMID: 30269132

5

New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the details.

Krajewski W, Rodríguez Faba O, Poletajew S, Palou J. Krajewski W, et al. World J Urol. 2020 Mar;38(3):805-806. doi: 10.1007/s00345-019-02680-3. Epub 2019 Feb 18. World J Urol. 2020. PMID: 30778671 No abstract available.

6

Expression of E-cadherin, β-catenin, and epithelial membrane antigen does not predict survival in patients with high-risk non-muscle-invasive bladder cancer.

Poletajew S, Fus Ł, Ilczuk T, Wojcieszak P, Sękowska M, Krajewski W, Wasiutyński A, Górnicka B, Radziszewski P. Poletajew S, et al. Among authors: krajewski w. Cent Eur J Immunol. 2018;43(4):421-427. doi: 10.5114/ceji.2018.79509. Epub 2018 Dec 31. Cent Eur J Immunol. 2018. PMID: 30799990 Free PMC article.

7

A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guérin immunotherapy.

Poletajew S, Krajewski W, Adamowicz J, Radziszewski P. Poletajew S, et al. Among authors: krajewski w. Anticancer Drugs. 2019 Jun;30(5):517-522. doi: 10.1097/CAD.0000000000000775. Anticancer Drugs. 2019. PMID: 30870228

8

The TaHG bladder cancer - the devil is as black as he is painted.

Krajewski W, Poletajew S. Krajewski W, et al. Cent European J Urol. 2019;72(1):76-77. doi: 10.5173/ceju.2018.1873. Epub 2019 Feb 15. Cent European J Urol. 2019. PMID: 31011449 Free PMC article. No abstract available.

9

Management of Intradiverticular Bladder Tumours: A Systematic Review.

Poletajew S, Krajewski W, Adamowicz J, Kołodziej A, Zdrojowy R, Radziszewski P. Poletajew S, et al. Among authors: krajewski w. Urol Int. 2020;104(1-2):42-47. doi: 10.1159/000503868. Epub 2019 Dec 18. Urol Int. 2020. PMID: 31851992

10

Technical developments in transurethral resection of bladder tumours.

Pastuszak A, Zdrojowy R, Poletajew S, Adamowicz J, Krajewski W. Pastuszak A, et al. Among authors: krajewski w. Contemp Oncol (Pozn). 2019;23(4):195-201. doi: 10.5114/wo.2019.91530. Epub 2019 Dec 30. Contemp Oncol (Pozn). 2019. PMID: 31992950 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

293 results

Search Page